Micronised fenofibrate.
Rationale and development of a new fenofibrate formulation is described. A lower dispersion of particles size and thereby a better absorption rate leads to a decrease of the daily dose and provides a better control of the amount absorbed. Improved reproducibility of the pharmacological and therapeutic effect is expected.
A
A
Munoz
J P
JP
Guichard
P
P
Reginault
D004339:Drug Compounding; D011345:Fenofibrate / Q000493:pharmacokinetics*; D006801:Humans; D066298:In Vitro Techniques; D007408:Intestinal Absorption; D010316:Particle Size; D011208:Powders
D011208:Powders; D011345:Fenofibrate